mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.07 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.07 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |